In AACC booth 2600, Beckman Coulter, Brea, Calif, has introduced the Beckman Coulter Diagnostics Difference?a unique integrated solution that focuses on achieving laboratory excellence by optimizing operational efficiency and clinical effectiveness.
The scalable combination of tools, insights, management systems, and process improvements is designed to enable healthcare enterprises of every size to manage a range of testing volumes and achieve fast, consistent turnaround times at peak workloads. The solutions target a number of diagnostic disciplines, including laboratory automation, chemistry, immunoassay, hematology, urinalysis, and microbiology.
In addition, Beckman Coulter is offering attendees a preview of products under development, such as a new low-volume hematology analyzer and a medium-volume chemistry platform.
“Laboratory test results are among today’s greatest influencers of patient-care decisions,” says Arnd Kaldowski, president of Beckman Coulter Diagnostics. “Because we know that successful healthcare organizations rely on laboratory excellence, we are driven to empower clinical laboratory professionals to meet their quality metrics and financial goals through innovative technology and our unwavering commitment to continuous improvement. This is evident in the Beckman Coulter diagnostics difference, which includes personalized expert attention, clinical data management tools, and the Danaher Business System—or DBS—philosophy, which is an integrated set of values and processes designed to yield the highest impact for performance and sustained success.”
“Our clinical laboratory customers tell us that standardizing processes to increase capacity, minimize errors, and reduce turnaround times is critical to their success,” says John Nosenzo, senior vice president of global customer operations at Beckman Coulter Diagnostics. “They are actively seeking a partner to help them achieve this goal. The DBS approach enables us to partner with diagnostic laboratories and their interdisciplinary healthcare associates to build and sustain a culture of continuous improvement across all aspects of patient care.”
For more information, visit AACC booth 2600 or Beckman Coulter Diagnostics.
